X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

TECHNOLOGY IN CANCER RESEARCH & TREATMENT

期刊標題檢索 TECHNOL CANCER 最新評論: As an associate editor of this journal, handling the manuscripts of th... (2024-02-15)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[TECHNOLOGY IN CANCER RESEARCH & TREATMENT]您好,您是該頁面的第 72427 位訪客。

期刊簡介
期刊名稱TECHNOLOGY IN CANCER RESEARCH & TREATMENT TECHNOLOGY IN CANCER RESEARCH & TREATMENT
LetPub Score
5.4
50 ratings
Rate

Reputation
6.3

Influence
4.1

Speed
8.0

期刊簡稱TECHNOL CANCER RES T
ISSN1533-0346
E-ISSN1533-0338
h-index56
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.400.6090.570
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q2186 / 404
Category: Medicine
Subcategory: Cancer Research
Q3141 / 230

自引率 (2023-2024)3.70%自引率趨勢
掲載範囲
Technology in Cancer Research & Treatment (TCRT) is a JCR-ranked, broad-spectrum, open access, peer-reviewed publication whose aim is to provide researchers and clinicians with a platform to share and discuss developments in the prevention, diagnosis, treatment, and monitoring of cancer.
官方網站http://tct.sagepub.com/
在線稿件提交https://us.sagepub.com/en-us/nam/technology-in-cancer-research-treatment/journal202330#submission-guidelines
開放訪問No
出版商SAGE Publications Inc.
主題領域医学
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年2002
每年文章數236每年文章數趨勢
黃金OA百分比91.82%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ3163/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1533-0346%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 2 Month(s)
競爭力 *來自作者的數據: About 80%
參考鏈接
相關期刊 【TECHNOLOGY IN CANCER RESEARCH & TREATMENT】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS326092
    CANCER RESEARCH310906
    BMC CANCER242779
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH197871
    INTERNATIONAL JOURNAL OF CANCER188166
    Asian Pacific Journal of Cancer Prevention184123
    CLINICAL CANCER RESEARCH180933
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY171555
    ONCOLOGY REPORTS171144
    CA-A CANCER JOURNAL FOR CLINICIANS163240
  •  

    TECHNOLOGY IN CANCER RESEARCH & TREATMENT TECHNOLOGY IN CANCER RESEARCH & TREATMENT
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [TECHNOLOGY IN CANCER RESEARCH & TREATMENT] 的評論撰寫評論
作者: Jamie0703


領域: 医学
審稿時間: 4.0 month(s)
結果: 修改後接受


撰寫評論

2024-02-15 22:10:25 評論於
As an associate editor of this journal, handling the manuscripts of this journal is really exhausting. The efficiency of peer review is extremely low, unless I invite people I know to review them, or else I can't find reviewers for a long time. Sometimes I have no choice but to act as both an editor and a reviewer, meeting the minimum requirements of two reviewers. I suggest authors to recommend reviewers in the cover letter (who are in a similar research field and have no conflict of interest). In cases where reviewers cannot be found, this may speed up the process. Anyway, as long as I see that the recommended reviewers have not published articles together, I am willing to accept one
(2) 讚! | Jamie0703

作者: 阳溪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-03 20:25:39 評論於
May I ask how long is the current review period?
(0) 讚! | 阳溪

作者: Dr. Scorpion


領域: 医学
審稿時間: 6.0 month(s)
結果: 修改後接受


撰寫評論

2019-10-29 13:32:16 評論於
The journal is slow and expert opinions are pertinent. However, the time for second revision is very long due to personal reasons. It has been 12 months since the submission. We are still waiting.

(0) 讚! | Dr. Scorpion

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [TECHNOLOGY IN CANCER RESEARCH & TREATMENT] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*